NBT Bank N A NY Decreases Holdings in iShares Biotechnology ETF $IBB

NBT Bank N A NY trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 11.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 25,047 shares of the financial services provider’s stock after selling 3,244 shares during the quarter. NBT Bank N A NY owned 0.06% of iShares Biotechnology ETF worth $3,169,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Ramirez Asset Management Inc. bought a new stake in iShares Biotechnology ETF in the first quarter valued at $26,000. Berkshire Money Management Inc. bought a new stake in iShares Biotechnology ETF in the second quarter valued at $28,000. Financial Gravity Asset Management Inc. bought a new stake in iShares Biotechnology ETF in the first quarter valued at $30,000. Woodside Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the first quarter valued at $31,000. Finally, CX Institutional bought a new stake in iShares Biotechnology ETF in the first quarter valued at $32,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $150.48 on Wednesday. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $151.79. The company’s fifty day moving average price is $139.85 and its 200-day moving average price is $130.21.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were issued a dividend of $0.0828 per share. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.